The Validation of Multifactor Model of Plasma Aβ(42) and Total-Tau in Combination With MoCA for Diagnosing Probable Alzheimer Disease

Alzheimer disease (AD) has an insidious onset and heterogeneous clinical symptoms. The well-accepted biomarkers for clinical diagnosis of AD include β-amyloid (Aβ) deposition and pathologic tau level within cerebral spinal fluid (CSF) and imaging AD pathology such as positive emission tomography (PE...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Fubin, Yi, Fang, Wang, Yuanyuan, Zhang, Shouzi, Guo, Yanjun, Du, Wenjin, Gao, Ya, Ren, Jingjing, Zhang, Haifeng, Liu, Lixin, Song, Haifeng, Wang, Luning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385244/
https://www.ncbi.nlm.nih.gov/pubmed/32792940
http://dx.doi.org/10.3389/fnagi.2020.00212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385244/
https://www.ncbi.nlm.nih.gov/pubmed/32792940
http://dx.doi.org/10.3389/fnagi.2020.00212

Ejemplares similares